Joseph Andrew Walewicz, Director at Mirati Therapeutics, holds 70.00K shares in Mirati Therapeutics (Ticker: MRTX), holds 522.19K shares in Neupath Health Inc. (Ticker: TSE:NPTH). Most recently, Joseph Andrew Walewicz ― shares of Mirati Therapeutics on ― for an estimated value of ―.

See the Hottest Stocks Based on Insider Trading >

Joseph Andrew Walewicz
Mirati Therapeutics (MRTX)
Director

Ranked #52,035 out of 100,285 Corporate Insiders

Profitable Transactions

3 out of 4 Profitable Transactions

Average Return

-1.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

NPTH

A breakdown of Joseph Andrew Walewicz's holdings

See the Top Stocks by Insiders

Insider Roles

Neupath Health Inc.
(NPTH)

Director

Roles that Joseph Andrew Walewicz holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Neupath Health Inc.
(NPTH)

Rating:Informative Buy

Date:May 04, 2023 - May 04, 2024

Return:+26.80%

The most profitable trade made by Joseph Andrew Walewicz

See the Latest Stocks Traded by Insiders

Joseph Andrew Walewicz's Trading History

MRTX

Mirati Therapeutics

―

$4.11M

NPTH

Neupath Health Inc.

Dec 12, 2024

Director

Informative Buy

29.30K

C$107.05K

List of latest transactions for each holding click on a transaction to see Joseph Andrew Walewicz's performance on stock

See All Insider Trading from Today

Joseph Andrew Walewicz insider profile FAQ

What is the percentage of profitable transactions made by Joseph Andrew Walewicz?

The percentage of profitable transactions made by Joseph Andrew Walewicz is 75%.

What is the average return per transaction made by Joseph Andrew Walewicz?

The average return per transaction made by Joseph Andrew Walewicz is -1.30%.

What stocks does Joseph Andrew Walewicz hold?

Joseph Andrew Walewicz holds: MRTX, TSE:NPTH stocks.

What was Joseph Andrew Walewicz’s latest transaction?

Joseph Andrew Walewicz latest transaction was an Uninformative Buy of ―.

What was Joseph Andrew Walewicz's most profitable transaction?

Joseph Andrew Walewicz’s most profitable transaction was an Informative Buy of TSE:NPTH stock on May 4, 2023. The return on the trade was 26.80%.

What is Joseph Andrew Walewicz's role in Mirati Therapeutics?

Joseph Andrew Walewicz's role in Mirati Therapeutics is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Joseph Andrew Walewicz Insider Profile

Joseph Andrew Walewicz Mirati Therapeutics (MRTX)Director